NAPLES, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leading global healthcare network focused on improving healthcare access and outcomes through data-driven solutions, proudly announces a new strategic partnership with 3X4 Genetics, a pioneering leader in personalized genetic insights. This collaboration will deliver enhanced health services and unique benefits to HealthLynked's members, advancing its mission to provide personalized and predictive healthcare options.
This partnership marks a significant step in HealthLynked's commitment to expanding its network of strategic alliances aimed at enhancing patient care. Over the coming months, HealthLynked plans to forge similar partnerships that will increase the range of services available to its members, with a focus on improving patient health through advanced diagnostics, wellness programs, and exclusive savings.
HealthLynked's CEO, Michael Dent, M.D., emphasized the value of these partnerships: "Our collaboration with 3X4 Genetics is a clear demonstration of HealthLynked's strategy to deliver cutting-edge healthcare solutions that enhance patient care. With 3X4 Genetics' focus on personalized genetic testing, we are providing our members with deeper insights into their health, allowing for more tailored treatments and preventive care strategies. This partnership exemplifies how HealthLynked is revolutionizing healthcare by connecting our members with industry-leading services that make a difference in their health outcomes."
3X4 Genetics, a company rooted in the integration of genetics and systems biology, is known for its sophisticated genetic testing services that provide individuals with personalized health insights. These insights empower individuals to make informed decisions about their health, spanning areas such as diet, fitness, and disease prevention. The company's CEO, Tony Hsu, highlighted the alignment between 3X4 Genetics and HealthLynked's mission to empower patients: "We are thrilled to partner with HealthLynked in bringing our innovative genetic solutions to a broader audience. Together, we are enabling patients to unlock the power of their genetics to optimize their health and wellness. This collaboration underscores our shared vision of a future where personalized healthcare is accessible to all."
HealthLynked members can now purchase the 3X4 Blueprint for personalized genetic testing for $299 directly through the HealthLynked website. To learn more and make a purchase, visit: 3X4 Genetics Blueprint.
This partnership underscores HealthLynked's vision of delivering proactive healthcare solutions by integrating advanced technologies such as AI and personalized medicine into its member services. As HealthLynked continues to build on this foundation, members can look forward to enhanced healthcare services, improved access to health insights, and exclusive savings as part of their HealthLynked membership.
For more information, visit www.healthlynked.com
About HealthLynked Corp.
HealthLynked Corp. is reshaping healthcare by offering nationwide telemedicine services, prescription discount vouchers, and tools to save on medical supplies. Its cloud-based platform allows patients to connect with healthcare providers for virtual consultations or book in-office appointments. With HealthLynked, members can also consolidate all their medical records into one secure location, easily accessible across all healthcare providers.
The platform empowers patients with AI-driven healthcare recommendations, streamlines appointment booking, and provides significant savings on medical supplies and prescriptions, ensuring a more affordable and coordinated healthcare experience.
Download the HealthLynked App
About 3X4 Genetics
3X4 Genetics is at the forefront of personalized healthcare, offering comprehensive genetic testing services that deliver actionable insights into diet, fitness, and overall health. Using an integrative systems biology approach, 3X4 Genetics helps individuals and healthcare providers make data-driven decisions to optimize health outcomes. For more information, visit www.3x4genetics.com.
Forward-Looking Statements & Risk Factors
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance, or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.
Investor Relations Contact
Michael Paisan
HealthLynked Corp.
1-800-928-7144
IR@healthlynked.com
Wire Service Contact:
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
